GalNAc-T5 Activators
Polypeptide N-acetylgalactosaminyltransferase 5, commonly referred to as GalNAc-T5, is an enzyme that plays a pivotal role in the post-translational modification of proteins through O-glycosylation. This particular type of glycosylation involves the attachment of a sugar molecule, N-acetylgalactosamine (GalNAc), to the hydroxyl groups of serine or threonine residues within a protein. GalNAc-T5 is part of a larger family of GalNAc-transferases, each with unique, yet sometimes overlapping, substrate specificities and expression patterns. The activity of GalNAc-T5 is essential for the proper function of various cellular processes, including signal transduction, protein stabilization, and the determination of protein half-life. As a key enzyme in cellular homeostasis, the expression of GalNAc-T5 is tightly controlled and can be influenced by a range of intracellular and extracellular signals.
Certain chemical compounds have been identified as potential activators that could induce the expression of GalNAc-T5. For instance, Tunicamycin may inadvertently upsurge the expression of GalNAc-T5 by disrupting N-linked glycosylation, thereby triggering a homeostatic cellular response to maintain glycosylation balance. Similarly, compounds like 5-Azacytidine could promote the transcription of GalNAc-T5 by causing DNA demethylation, which in turn may enhance the expression of genes involved in glycosylation pathways. Epigenetic modulators such as Sodium Butyrate are known to create a transcription-friendly chromatin state, potentially leading to an increase in GalNAc-T5 expression. Furthermore, signaling molecules like Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C and initiate a signaling cascade that may culminate in the elevated transcription of GalNAc-T5. These activators highlight the intricate network of regulatory mechanisms that can influence the expression of this crucial enzyme, and understanding these interactions is key to comprehending the complex biology of O-glycosylation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin may initiate the unfolded protein response by blocking N-linked glycosylation, potentially leading to a compensatory upsurge in the expression of O-glycosylation enzymes, such as GalNAc-T5, to mitigate the stress response. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could lead to the hypomethylation of gene promoters, which may spark increased transcription of genes, including those encoding for enzymes like GalNAc-T5 that are crucial in the O-glycosylation pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate has been shown to stimulate the transcriptional activity of certain genes through its interaction with multiple cellular pathways, which may include the upregulation of glycosyltransferases such as GalNAc-T5. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, by activating its receptors, can prompt the transcription of several genes. This action could potentially lead to an upsurge in the expression of enzymes like GalNAc-T5, responsible for the O-glycosylation in cells. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, can cause chromatin to remain in a more transcriptionally active state, which might stimulate the transcription of glycosyltransferases, potentially including GalNAc-T5. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
The active metabolites of Cholecalciferol can bind to the vitamin D receptor, leading to the transcriptional activation of genes. This binding may elevate the expression levels of enzymes such as GalNAc-T5. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, by activating protein kinase C, can initiate a cascade that alters gene expression profiles. This could result in the enhanced transcription and subsequent upregulation of GalNAc-T5 expression in certain cell types. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol can engage estrogen receptors and initiate a sequence of events leading to the transcriptional activation of genes. This hormonal signal may stimulate the increased expression of GalNAc-T5. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, through glucocorticoid receptor activation, can augment transcription of certain genes. This glucocorticoid may specifically induce the expression of glycosyltransferases, which includes GalNAc-T5. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich sequences in DNA, typically inhibiting Sp1 transcription factors. This binder could indirectly stimulate the upregulation of alternate glycosyltransferase genes, potentially including GalNAc-T5. | ||||||